1. Home
  2. ROIV vs TS Comparison

ROIV vs TS Comparison

Compare ROIV & TS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$38.99

Market Cap

28.7B

Sector

Health Care

ML Signal

HOLD

Logo Tenaris S.A.

TS

Tenaris S.A.

HOLD

Current Price

$55.97

Market Cap

27.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
TS
Founded
2014
2001
Country
United Kingdom
Luxembourg
Employees
721
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
28.7B
27.3B
IPO Year
2021
2002

Fundamental Metrics

Financial Performance
Metric
ROIV
TS
Price
$38.99
$55.97
Analyst Decision
Strong Buy
Buy
Analyst Count
9
5
Target Price
$28.94
$58.80
AVG Volume (30 Days)
8.5M
1.0M
Earning Date
05-28-2026
05-06-2026
Dividend Yield
N/A
2.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,260,000.00
N/A
Revenue This Year
N/A
$1.53
Revenue Next Year
$744.61
$3.59
P/E Ratio
N/A
$12.59
Revenue Growth
N/A
N/A
52 Week Low
$14.50
$33.71
52 Week High
$42.50
$64.60

Technical Indicators

Market Signals
Indicator
ROIV
TS
Relative Strength Index (RSI) 55.79 51.59
Support Level $33.15 $54.39
Resistance Level $42.50 $58.72
Average True Range (ATR) 1.45 1.11
MACD 0.05 0.02
Stochastic Oscillator 60.80 42.46

Price Performance

Historical Comparison
ROIV
TS

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About TS Tenaris S.A.

Tenaris SA is engaged in the manufacture and supply of steel pipe products and related services for the energy industry and other industrial applications. The company has one reportable segment, Tubes, which includes the production and sale of steel tubular products such as OCTG, line pipe, and mechanical and structural tubes, mainly for the oil and gas industry. It operates an integrated network of manufacturing, research, and service facilities across the Americas, Europe, the Middle East, Asia, and Africa.

Share on Social Networks: